What's new

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised

Mar 5, 2025 - 14:19
 0
Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

The Great PMS Debate: Why a Best-in-Class PMS Beats an All-in-One Platform

Next Article

A Universal Self-Triggered Passive Management Strategy for Output Power of Tribo...

Related Posts

European medicines agencies network strategy (EMANS) to 2028 webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 February 2025, 13:00 (CET) to 13 February 2025, 17:00 (CET)

European medicines agencies network strategy (EMANS) to...

Feb 18, 2025  0

EMEA-002798-PIP04-23

EMEA-002798-PIP04-23

Feb 13, 2025  0

Referral: Azithromycin-containing medicinal products for systemic use, azithromycin Article 31 referrals Under evaluation, 05/03/2025

Referral: Azithromycin-containing medicinal products fo...

Mar 5, 2025  0